Reimbursed Care Access in Curaçao

Currently classified as a strictly controlled substance under national and international drug-scheduling frameworks, with no authorized medical use outside of approved clinical research. International control of psilocybin is reflected in the 1971 UN Convention/INCB scheduling and national-level implementations typically prohibit non-research possession, manufacture, or distribution. # #.

Currently classified as a strictly controlled substance under national and international drug-scheduling frameworks, with no authorized medical use outside of approved clinical research. MDMA remains controlled under the 1971 Convention and nation-states following standard scheduling generally restrict all clinical or compassionate access to formal, authorized research programs. # #.

Esketamine (marketed as SPRAVATO®) is an FDA- and regulator-approved psychiatric product in certain jurisdictions for treatment‑resistant depression and related indications, and when available is administered under a restricted REMS program and subject to clinic-based administration requirements. # #. However, Curaçao has experienced an operational halt in new pharmaceutical registrations since December 2023, meaning new branded medicines (including esketamine) cannot be registered/approved through the local registration committee while the regulatory vacancy persists; consequently esketamine is unlikely to be registered or reimbursed locally at present. Local clinicians would therefore face administrative barriers to importation, reimbursement, or routine clinical use of the proprietary product. #.

Ketamine is listed on the WHO Model List of Essential Medicines for its established role in anesthesia and analgesia, and is commonly used worldwide in hospital and emergency settings; this international recognition supports legitimate medical availability for anesthesia, pain, and—in many countries—off-label psychiatric uses (e.g., IV ketamine for severe or treatment-resistant depression) when provided under medical supervision. #.

In Curaçao, there is no public indication that ketamine has been banned for clinical use; like most jurisdictions, ketamine is expected to be available for anesthetic and hospital use under ministerial/health facility licensing and procurement pathways. That said, off-label psychiatric uses (such as IV ketamine for depression) would be clinician-driven, typically paid privately or through private health insurers on a case-by-case basis rather than through formal, reimbursed public benefit schemes—especially given the local regulatory difficulties for registering new therapeutic indications or novel formulations. The regulatory gap in Curaçao’s drug registration process further complicates formal introduction of new protocolized, reimbursed services for novel psychiatric indications. # #.

Currently classified as a strictly controlled substance under national and international drug-scheduling frameworks, with no authorized medical use outside of approved clinical research. DMT and ayahuasca-related preparations are internationally controlled and typically prohibited outside tightly regulated scientific or religious exemptions. # #.

Currently classified as a strictly controlled substance under national and international drug-scheduling frameworks, with no authorized medical use outside of approved clinical research. 5‑MeO‑DMT is included in international control frameworks and is typically treated the same as other schedule‑I hallucinogens at the national level absent explicit regulatory medical pathways. # #.

Currently classified as a strictly controlled substance under national and international drug-scheduling frameworks, with no authorized medical use outside of approved clinical research. Although some countries permit or tolerate ibogaine in specialized addiction‑treatment settings, Curaçao offers no established authorized medical pathway or publicly reimbursed program for ibogaine; importation or clinical use would, if attempted, face strong legal and regulatory barriers. # #.

Currently classified as a strictly controlled substance under national and international drug-scheduling frameworks, with no authorized medical use outside of approved clinical research. Plant preparations containing DMT (ayahuasca) fall under international controls and are generally prohibited except in narrowly defined research or religious contexts where national laws explicitly create exceptions; no such public exemption for Curaçao is documented. # #.

Currently classified as a strictly controlled substance under national and international drug-scheduling frameworks, with no authorized medical use outside of approved clinical research. Mescaline (and peyote derivatives) is internationally controlled and national implementations typically prohibit non-research use. # #.

Currently classified as a strictly controlled substance under national and international drug-scheduling frameworks, with no authorized medical use outside of approved clinical research. Members of the 2C family are commonly scheduled or covered by analogue/blanket provisions in many national laws, and Curaçao maintains prohibitive controls consistent with international obligations. # #.